Cogent Biosciences Inc. (COGT) NASDAQ

$6.50 (0.01) (-0.15%)

Market Cap: $622.44M

As of 04/15/24 03:59 PM EDT. Market closed.

(COGT)

Cogent Biosciences Inc. (COGT)
NASDAQ

$6.50
(0.01) (-0.15%)

Market Cap: $622.44M

As of 04/15/24 03:59 PM EDT. Market closed.

Add to Portfolio

unum therapeutics is a cambridge, massachusetts-based cellular therapeutics company ushering in a new wave of innovation in cancer immunotherapy. unum was built to transform cancer treatment through the discovery, development and commercialization of novel antibody-coupled cellular immunotherapies. unum has built an antibody-coupled t-cell receptor (actr) platform that, when combined with ... read more

unum therapeutics is a cambridge, massachusetts-based cellular therapeutics company ushering in a new wave of innovation in cancer immunotherapy. unum was built to transform cancer treatment through the discovery, development and commercialization of novel antibody-coupled cellular immunotherapies. unum has built an antibody-coupled t-cell receptor (actr) platform that, when combined with tumor-specific antibodies, directs an individual’s cytotoxic t-lymphocytes (ctls) to kill tumor cells. in contrast to other approaches that hit a single target and treat a narrow set of tumors, unum’s approach is not restricted by antigens and may have applications for treating many types of cancers. unum’s vision: a single cell therapy that can augment the activity of multiple antibodies to treat many different cancers. unum's lead program based on actr technology is currently in phase i clinical testing to assess safety and efficacy in certain forms of leukemia and lymphoma. in parallel, unum is act read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Andrew R. Robbins
Full Time Employees
146
CEO Compensation (Base)
$325,000
CEO Compensation (Total)
$2.72M
URL
Address
275 Wyman Street, Floor 3, MA, Waltham, 02451.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Andrew R. Robbins
Full Time Employees
146
CEO Compensation (Base)
$325,000
CEO Compensation (Total)
$2.72M
Address
275 Wyman Street, Floor 3, MA, Waltham, 02451.
PRICE CHART FOR COGENT BIOSCIENCES INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$6.50
Previous Close
$6.51
Days Range
$6.44 - $6.60
52 week range
$3.67 - $13.50
Volume
1,211,458
Avg. Volume (30 days)
1,323,075
Market Cap
$622.44M
Dividend Yield
-
P/E
-
Shares Outstanding
95,613,396
Open
$6.50
Previous Close
$6.51
Days Range
$6.44 - $6.60
52 week range
$3.67 - $13.50
Volume
1,211,458
Avg. Volume (30 days)
1,323,075
Market Cap
$622.44M
Dividend Yield
-
P/E
-
Shares Outstanding
95,613,396
FINANCIAL STATEMENTS FOR COGENT BIOSCIENCES INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR COGENT BIOSCIENCES INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Fairmount Funds Management LLC10% OwnerFeb 16, 2024 Option Exercise$7.501,166,6668,749,9954,438,790Feb 16, 2024, 06:43 PM
Fairmount Funds Management LLC10% OwnerJun 09, 2023 Buy$12.00800,0009,600,0003,272,124Jun 13, 2023, 04:07 PM
Sachs JessicaChief Medical OfficerJun 30, 2022 Option Exercise$7.396224,600622Jul 01, 2022, 09:19 AM
Fairmount Funds Management LLC10% OwnerJun 16, 2022 Buy$8.251,200,0009,900,0002,472,124Jun 21, 2022, 10:02 AM
Sachs JessicaChief Medical OfficerDec 31, 2021 Option Exercise$6.826744,595674Jan 04, 2022, 09:25 PM
Green John L.Chief Financial OfficerApr 26, 2021 Sale$8.8617,813157,8233,841Apr 28, 2021, 08:30 PM
CAMPANA DARIO10% OwnerMay 07, 2020 Sale$0.41100,00041,4303,393,314Oct 08, 2020, 05:43 PM
CAMPANA DARIO10% OwnerApr 14, 2020 Sale$0.4098,97339,7214,558,275Oct 08, 2020, 05:43 PM
CAMPANA DARIO10% OwnerApr 28, 2020 Sale$0.4115,0486,1684,095,114Oct 08, 2020, 05:43 PM
CAMPANA DARIO10% OwnerMay 06, 2020 Sale$0.401,8007223,493,314Oct 08, 2020, 05:43 PM
CAMPANA DARIO10% OwnerApr 09, 2020 Sale$0.33420,292138,1504,613,242Oct 08, 2020, 05:43 PM
CAMPANA DARIO10% OwnerApr 27, 2020 Sale$0.40242,57997,8084,110,162Oct 08, 2020, 05:43 PM
CAMPANA DARIO10% OwnerMay 05, 2020 Sale$0.40135,48454,4373,495,114Oct 08, 2020, 05:43 PM
CAMPANA DARIO10% OwnerApr 08, 2020 Sale$0.35100355,033,534Oct 08, 2020, 05:43 PM
CAMPANA DARIO10% OwnerApr 20, 2020 Sale$0.4012,6065,0504,352,741Oct 08, 2020, 05:43 PM
CAMPANA DARIO10% OwnerMay 04, 2020 Sale$0.404,7951,9213,630,598Oct 08, 2020, 05:43 PM
CAMPANA DARIO10% OwnerApr 07, 2020 Sale$0.3511,4003,9905,033,634Oct 08, 2020, 05:43 PM
CAMPANA DARIO10% OwnerMay 12, 2020 Sale$0.4698,20045,5453,095,114Oct 08, 2020, 05:43 PM
CAMPANA DARIO10% OwnerApr 17, 2020 Sale$0.3965,54025,5744,365,347Oct 08, 2020, 05:43 PM
CAMPANA DARIO10% OwnerMay 01, 2020 Sale$0.418003283,635,393Oct 08, 2020, 05:43 PM
CAMPANA DARIO10% OwnerApr 06, 2020 Sale$0.3550,08017,5285,045,034Oct 08, 2020, 05:43 PM
CAMPANA DARIO10% OwnerMay 11, 2020 Sale$0.45100,00045,4963,271,033Oct 08, 2020, 05:43 PM
CAMPANA DARIO10% OwnerApr 16, 2020 Sale$0.386002304,430,887Oct 08, 2020, 05:43 PM
CAMPANA DARIO10% OwnerApr 30, 2020 Sale$0.4075,99430,5573,636,193Oct 08, 2020, 05:43 PM
CAMPANA DARIO10% OwnerMay 08, 2020 Sale$0.46100,00046,3903,293,314Oct 08, 2020, 05:43 PM
CAMPANA DARIO10% OwnerApr 15, 2020 Sale$0.3882,78231,7974,431,487Oct 08, 2020, 05:43 PM
CAMPANA DARIO10% OwnerApr 29, 2020 Sale$0.41382,927155,5073,712,187Oct 08, 2020, 05:43 PM
Venrock Healthcare Capital Partners III, L.P.10% OwnerAug 14, 2020 Buy$2.30100,000230,0004,004,273Aug 18, 2020, 06:19 PM
Venrock Healthcare Capital Partners III, L.P.10% OwnerAug 18, 2020 Buy$2.62101,000264,6204,355,273Aug 18, 2020, 06:19 PM
Venrock Healthcare Capital Partners III, L.P.10% OwnerAug 17, 2020 Buy$2.57250,000642,5004,254,273Aug 18, 2020, 06:19 PM
Green John L.Chief Financial OfficerJul 06, 2020 Option Exercise$2.2031,87370,12177,586Jul 08, 2020, 07:40 PM
Ettenberg SethChief Scientific OfficerMar 25, 2019 Option Exercise$0.1811,4852,06711,485Mar 26, 2019, 04:23 PM
Ettenberg SethChief Scientific OfficerMar 25, 2019 Sale$4.1211,48547,3340Mar 26, 2019, 04:23 PM
Ettenberg SethChief Scientific OfficerFeb 25, 2019 Option Exercise$0.1811,4852,06711,485Feb 26, 2019, 04:36 PM
Ettenberg SethChief Scientific OfficerFeb 25, 2019 Sale$4.2511,48548,8530Feb 26, 2019, 04:36 PM
Ettenberg SethChief Scientific OfficerDec 26, 2018 Option Exercise$0.1811,4852,06711,485Dec 28, 2018, 07:09 PM
Ettenberg SethChief Scientific OfficerDec 26, 2018 Sale$4.0511,48546,4870Dec 28, 2018, 07:09 PM
Ettenberg SethChief Scientific OfficerNov 26, 2018 Option Exercise$0.1811,4852,06711,485Nov 26, 2018, 07:54 PM
Ettenberg SethChief Scientific OfficerNov 26, 2018 Sale$7.0011,48580,4440Nov 26, 2018, 07:54 PM
Ettenberg SethChief Scientific OfficerOct 25, 2018 Option Exercise$0.1811,4852,06711,485Oct 29, 2018, 04:41 PM
Ettenberg SethChief Scientific OfficerOct 25, 2018 Sale$8.4611,48597,2010Oct 29, 2018, 04:41 PM
Ettenberg SethChief Scientific OfficerSep 25, 2018 Option Exercise$0.1811,4852,06711,485Sep 26, 2018, 06:41 PM
Ettenberg SethChief Scientific OfficerSep 25, 2018 Sale$12.4711,485143,1810Sep 26, 2018, 06:41 PM
FMR LLCSee Remark 1Apr 03, 2018 Buy$12.0094,0521,128,624452,115Apr 05, 2018, 12:27 PM
Atlas Venture Fund IX, L.P.10% OwnerApr 03, 2018 Buy$12.0094,0521,128,6243,361,535Apr 03, 2018, 05:11 PM
Booth BruceDirectorApr 03, 2018 Buy$12.0094,0521,128,6243,361,535Apr 03, 2018, 05:07 PM
Ratcliffe LiamDirectorApr 03, 2018 Buy$12.00550,0006,600,000897,773Apr 03, 2018, 12:00 AM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Fairmount Funds Management LLC10% Owner02/16/20248,749,995
Fairmount Funds Management LLC10% Owner06/09/20239,600,000
Sachs JessicaChief Medical Officer06/30/20224,600
Fairmount Funds Management LLC10% Owner06/16/20229,900,000
Sachs JessicaChief Medical Officer12/31/20214,595
Green John L.Chief Financial Officer04/26/2021157,823
CAMPANA DARIO10% Owner05/07/202041,430
CAMPANA DARIO10% Owner04/14/202039,721
CAMPANA DARIO10% Owner04/28/20206,168
CAMPANA DARIO10% Owner05/06/2020722
CAMPANA DARIO10% Owner04/09/2020138,150
CAMPANA DARIO10% Owner04/27/202097,808
CAMPANA DARIO10% Owner05/05/202054,437
CAMPANA DARIO10% Owner04/08/202035
CAMPANA DARIO10% Owner04/20/20205,050
CAMPANA DARIO10% Owner05/04/20201,921
CAMPANA DARIO10% Owner04/07/20203,990
CAMPANA DARIO10% Owner05/12/202045,545
CAMPANA DARIO10% Owner04/17/202025,574
CAMPANA DARIO10% Owner05/01/2020328
CAMPANA DARIO10% Owner04/06/202017,528
CAMPANA DARIO10% Owner05/11/202045,496
CAMPANA DARIO10% Owner04/16/2020230
CAMPANA DARIO10% Owner04/30/202030,557
CAMPANA DARIO10% Owner05/08/202046,390
CAMPANA DARIO10% Owner04/15/202031,797
CAMPANA DARIO10% Owner04/29/2020155,507
Venrock Healthcare Capital Partners III, L.P.10% Owner08/14/2020230,000
Venrock Healthcare Capital Partners III, L.P.10% Owner08/18/2020264,620
Venrock Healthcare Capital Partners III, L.P.10% Owner08/17/2020642,500
Green John L.Chief Financial Officer07/06/202070,121
Ettenberg SethChief Scientific Officer03/25/20192,067
Ettenberg SethChief Scientific Officer03/25/201947,334
Ettenberg SethChief Scientific Officer02/25/20192,067
Ettenberg SethChief Scientific Officer02/25/201948,853
Ettenberg SethChief Scientific Officer12/26/20182,067
Ettenberg SethChief Scientific Officer12/26/201846,487
Ettenberg SethChief Scientific Officer11/26/20182,067
Ettenberg SethChief Scientific Officer11/26/201880,444
Ettenberg SethChief Scientific Officer10/25/20182,067
Ettenberg SethChief Scientific Officer10/25/201897,201
Ettenberg SethChief Scientific Officer09/25/20182,067
Ettenberg SethChief Scientific Officer09/25/2018143,181
FMR LLCSee Remark 104/03/20181,128,624
Atlas Venture Fund IX, L.P.10% Owner04/03/20181,128,624
Booth BruceDirector04/03/20181,128,624
Ratcliffe LiamDirector04/03/20186,600,000
Load More Insider Transactions
FUNDS WITH A POSITION IN COGENT BIOSCIENCES INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.6,755,5840.00101%9.9%Other
SUVRETTA CAPITAL MANAGEMENT, LLC5,481,0341.09%47.72%Growth At A Reasonable Price
VIVO CAPITAL, LLC2,244,9411.08%No changeOther
GEODE CAPITAL MANAGEMENT, LLC1,728,7820.00106%4.95%Other
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)1,089,3450.12%No changeOther
PLATINUM INVESTMENT MANAGEMENT LTD475,6340.11%-0.04%Growth At A Reasonable Price, Value
CANDRIAM S.C.A.232,4870.00944%-70.1%Other
FISHER ASSET MANAGEMENT, LLC101,7910.00032%48.45%Other
D. E. SHAW & CO., INC.58,8010.0003%-46.8%Other
TUDOR INVESTMENT CORP ET AL58,0310.00275%23.55%Event Driven, Other
RENAISSANCE TECHNOLOGIES LLC26,2680.00024%NewOther
FARALLON CAPITAL MANAGEMENT LLC17,0000.0005%No changeEvent Driven, Value
CHANGE IN SHARES OUTSTANDING FOR COGENT BIOSCIENCES INC
STOCK BUYBACKS FOR COGENT BIOSCIENCES INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.75%
1Q
12/31/2023
06/30/2023
16.13%
2Q
12/31/2023
03/31/2023
22.72%
3Q
12/31/2023
12/31/2022
47.78%
4Q
12/31/2023
09/30/2022
24.77%
5Q
12/31/2023
06/30/2022
75.76%
6Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.75%
1Q
06/30/2023
16.13%
2Q
03/31/2023
22.72%
3Q
12/31/2022
47.78%
4Q
09/30/2022
24.77%
5Q
06/30/2022
75.76%
6Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR COGENT BIOSCIENCES INC
LOADING...